TG Therapeutics has announced that it has received an accelerated FDA approval for Ukoniq (umbralisib) used to treat for two types of blood cancer.

Meitheal Pharmaceuticals, a generic drug maker, has recalled one lot of cisatracurium besylate, a muscle relaxant. The lot was distributed between August 19, 2020 and January 4, 2021.

With COVID-19 vaccinations stalling, a new antibody combination treatment by Eli Lilly has shown positive Phase III data of more than 1,000 high-risk patients with COVID.

2020 had its ups and downs but in the world of biopharma there were some big M&A deals that took place. Click here to read about the top 10 M&A of 2020.

In an effort to market direct-to-consumer, Jazz has launched a new marketing campaign and ramped up its salesforce for Sunosi with 50 new employees.